HLA DR4

Overview

  • EPIC Code:
  • Soft Test Code:
  • MSOT
  • Send Out Test Code:
  • 104548
Alternate Names
  • HLA-DR4, Flow Cytometry
Clinical Significance

Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of lyme arthritis from infection with Borrelia burgdorferi or vaccination with lyme vaccine.


Specimen Collection & Preparation

Specimen Requirements

10.0 mL Whole Blood in a Yellow Top Tube - ACD


Transport And Storage

72 hours Ambient


Collection Instructions

Collect only Monday through Thursday 

Must be to testing facility with in 24 hours of collection


Minimum Volume

1.0 mL Whole Blood


Neonatal Volume

Clinical Interpretation

Reference Range:

A positive result indicates the presence of HLA-DR4 antigen which is associated with an increased risk of an adverse reaction to vaccination with Lyme disease vaccine


Methodology:
  • Flow Cytometry (FC)
Clinical Significance

Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of lyme arthritis from infection with Borrelia burgdorferi or vaccination with lyme vaccine.


Production Schedule

Sites Performed
  • Quest - Chantilly to San Juan Capistrano
Days Performed
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Departments
  • Sendouts - Miscellaneous
Turn Around Time

3 to 4 days


Coding & Compliance

CDM

86816


CPT Coding

00913333